Thursday, April 12, 2012
W Hotel Washington
Agenda
8:30 a.m.: Opening Remarks
Susan Dentzer, Editor-in-Chief, Health Affairs
8:40 a.m.: Remarks
J. Ross Maclean, Vice President, Health Services, Bristol-Myers Squibb
Dana Goldman, Director, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California
8:50 a.m.: The Value Of Higher Cancer Spending in the United States Versus Europe
Tomas J. Philipson, Daniel Levin Professor of Public Policy Studies, Harris School, University of Chicago
9:00 a.m.: How Cancer Patients Assign Value To Hope
Darius Lakdawalla, Director of Research, Schaeffer Center for Health Policy and Economics, University of Southern California
John A. Romley, Research Assistant Professor, School of Policy, Planning and Development, and Economist, Leonard D. Schaeffer Center for Health Economics and Policy, University of Southern California
Q & A
10:00 a.m.: Break
10:15 a.m.: Challenges Of Assessing Value In Cancer Care For Medicare And Other Payers
Peter Neumann, Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Professor of Medicine, Tufts University School of Medicine
Peter Ubel, Professor of Marketing and Public Policy, Duke University
10:45 a.m.: Are We Spending Money Appropriately In Cancer Care: The Case Of Prostate Cancer
Danil V. Makarov, Assistant Professor of Urology, New York University School of Medicine, and Assistant Professor of Health Policy, NYU Wagner School of Public Service
Jean Mitchell, Professor, Georgetown University Public Policy Institute
Bruce L. Jacobs, Fellow in Urologic Oncology and Health Services Research, University of Michigan
Joshua N. Mirkin, First-Year Medical Student, State University of New York Downstate College of Medicine
Q & A
Noon: Break for Box Lunches
12:15 p.m.: The Case For Lung Cancer Screening of High-Risk Patients
Bruce S. Pyenson, Principal, Milliman
12:30 p.m.: Improving Payment And Delivery Of Cancer Care
Lee N. Newcomer, Senior Vice President, Oncology, Genetics and Women’s Health, United Healthcare (via telephone)
Douglas W. Blayney, Ann and John Doerr Medical Director, Stanford University Cancer Center
1:00 p.m.: Variations, Best Practices and Patients’ Choices In Advanced Cancer And End of Life Care
Nancy E. Morden, Dartmouth Institute for Health Policy and Clinical Practice
Amy J. Berman, Breast cancer patient, Narrative Matters author, and Senior Program Officer, John A. Hartford Foundation
Q & A
1:30 p.m.: Adjourn
The briefing was made possible by funding support from Bristol-Myers Squibb; the Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California; and Precision Health Economics.